Skip To Main Content
Lilly
Menu closed
Lilly
  • Medical Home
  • Medical Education
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Ulcerative Colitis
        • COVID-19
        • Headache Disorders
        • Neurodegeneration
        • Breast Cancer
        • Hematologic Cancer
        • Axial Spondyloarthritis
        • Psoriatic Arthritis
        • Rheumatoid Arthritis
        • Resources
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Depression
        • Headache Disorders
        • Breast Cancer
        • Gastrointestinal Cancer
        • Oncology General
        • Osteoporosis
        • Rheumatoid Arthritis
        • Resources
  • Independent Medical Education
      • Alopecia Areata
      • Atopic Dermatitis
      • Psoriasis
    • Diabetes
      • Ulcerative Colitis
      • COVID-19
      • Headache Disorders
      • Neurodegeneration
    • Obesity
      • Breast Cancer
      • Gastrointestinal Cancer
      • Hematologic Cancer
      • Non-small Cell Lung Cancer
      • Prostate Cancer
      • Oncology General
      • Precision Medicine and Diagnostics
      • Axial Spondyloarthritis
      • Systemic Lupus Erythematosus
      • Psoriatic Arthritis
      • Rheumatoid Arthritis
  • Chat Contact Us

Disease Education Resources

Dermatology

Please select your disease state of interest to explore medical education resources.

Atopic Dermatitis

Eczchanges: A case study approach to recognizing and managing mental health comorbidities in patients with atopic dermatitis with Dr Valerie Callender
Play Video

Eczchanges: A case study approach to recognizing and managing mental health comorbidities in patients with atopic dermatitis with Dr Valerie Callender

Dr. Valerie Callender offers guidance to health care professionals on how to effectively recognize and manage mental health comorbidities in their patients with atopic dermatitis.

Eczchanges: A case study approach to treating and managing atopic dermatitis in patients with skin of color with Dr Valerie Callender
Play Video

Eczchanges: A case study approach to treating and managing atopic dermatitis in patients with skin of color with Dr Valerie Callender

Dr. Valerie Callender offers guidance to health care professionals on how to effectively assess and treat atopic dermatitis (AD) in patients with skin of color.

Expert Insights in Atopic Dermatitis (AD)
Play Video

Expert Insights in Atopic Dermatitis (AD)

A series of short videos featuring International Thought Leaders to raise awareness and increase understanding of the key challenges in management of AD that combines evidence-based research with expert insights to provide meaningful, patient-centric education.

Video series
IL-13 in Atopic Dermatitis
Play Video

IL-13 in Atopic Dermatitis

This video describes the role of the cytokine IL-13 in the pathophysiology of atopic dermatitis, as well as IL-13 signaling.

Systemic Patient in Atopic Dermatitis: Itch-dominant Patients
Play Video

Systemic Patient in Atopic Dermatitis: Itch-dominant Patients

Dr. Jonathan Silverberg and Dr. Eric Simpson discuss the concept of “itch-dominant patients” as a true subset of atopic dermatitis and highlight a real-world study with longitudinal data.

Systemic Patient in Atopic Dermatitis: Key Questions for Identification
Play Video

Systemic Patient in Atopic Dermatitis: Key Questions for Identification

Dr. Jonathan Silverberg and Dr. Eric Simpson discuss key questions to ask a patient with atopic dermatitis when assessing if the patient is eligible for an advanced systemic therapy.

Systemic Patient in Atopic Dermatitis: Long-term Control
Play Video

Systemic Patient in Atopic Dermatitis: Long-term Control

Dr. Jonathan Silverberg and Dr. Eric Simpson share clinical study data to elaborate on the importance of long-term disease control and symptoms fluctuation for patients with atopic dermatitis.

Systemic Patient in Atopic Dermatitis: Who is a Systemic Patient?
Play Video

Systemic Patient in Atopic Dermatitis: Who is a Systemic Patient?

Dr. Jonathan Silverberg and Dr. Eric Simpson discuss how to define a systemic patient with atopic dermatitis based on topical treatment failure.

The Role of IL-13 and Mechanism of Disease in Atopic Dermatitis
Play Video

The Role of IL-13 and Mechanism of Disease in Atopic Dermatitis

This video summarizes the role of an IL-13 receptor in the mechanism of disease in atopic dermatitis.

Unravel AD: Discussions in Systemic Therapy Education Tool

Unravel AD: Discussions in Systemic Therapy Education Tool

Unravel AD is a guided education tool featuring patient cases, that includes topics such as assessment, education / counseling and therapy considerations.

Tool
Battle of the 2 Titans Discussion Guide: Who is a systemic patient in atopic dermatitis?

Resource for dermatologists that can be used to facilitate a thoughtful 30-minute debate with a peer around when an atopic dermatitis patient is eligible for an advanced systemic treatment.

Eczchanges in Atopic Dermatitis - A Skin of Color and Mental Health HCP Summary

A summary of resources for health care professionals to effectively support atopic dermatitis (AD) in patients with skin of color and mental health comorbidities.

Eczchanges: Assessing and treating atopic dermatitis in your patients with skin of color

A resource for health care professionals to effectively assess and treat atopic dermatitis (AD) in patients with skin of color.

Eczchanges: Recognizing and managing mental health comorbidities in your patients with atopic dermatitis

A resource for health care professionals to recognize and manage mental health comorbidities in their patients with atopic dermatitis.

Not Just Scratching the Surface: A Look into the role of IL-13 in the Immunopathogenesis of AD (ISDS-2021)

Dr. Emma Guttman-Yassky hosts a panel discussion about the Evolving Understanding of IL-13 in the Pathophysiology of AD, Type 2 Inflammation and Chronic Itch, and IL-13 and Neuronal Itch.




Patient Education Resources

Explore our library of patient based education materials to aid in HCP to patient interactions.

Review patient resources
  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

To speak to customer support:
Call (XXX) XXX-XXXX

This site is intended for US Healthcare Professionals only.

4.1.7 03/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

Facebook Twitter
Lilly